aflibercept 2.0 mg
REG-2014-11-006
Approved small_molecule completed
Quick answer
aflibercept 2.0 mg for Diabetic Macular Edema is a Approved program (small_molecule) at REGENERON PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- REGENERON PHARMACEUTICALS, INC.
- Indication
- Diabetic Macular Edema
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed